500 cancer patients join quest to unlock precision medicine secrets
NCT ID NCT05403177
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study is collecting detailed genetic and health information from 500 people with various cancers, including breast, lung, and leukemia. The goal is to create a shared database that helps researchers develop more personalized treatments. Participants provide samples and data, but no experimental drugs are tested.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this could accelerate personalized cancer treatments by creating a rich dataset for researchers.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly benefit participants and results depend on data quality and collaboration.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kingston Health Sciences Centre
RECRUITINGKingston, Ontario, K7L 2V7, Canada
-
Ottawa Health Research Institute
NOT_YET_RECRUITINGOttawa, Ontario, K1Y 4E9, Canada
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G2M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a new tracer light up hidden prostate cancer?
- Can a plasma beam stop colon polyps from coming back?
- Can a new drug shield nerves from Chemotherapy's side effects?
- Can a simple CT scan catch lung cancer earlier in kuwait?
- A stitch in time: could a device make abdominal closure safer?